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Abstract
Background: Some studies have raised the question about whether the good results obtained
with the Charnley prosthesis could be replicated at general hospitals when it comes to the
frequency of early complications and failure rates, both of which would be higher than those
published by centres devoted to hip arthroplasties.
Methods: We reviewed the results of 404 Low Friction Arthroplasties of the hip implanted
between 1976 and 1993 in a general hospital by general orthopaedic surgeons. For the survival
analysis, the end-point chosen would be the chirurgical revision of any of the prosthetic
components for whatever reason.
Results: The complications were 16 dislocations (4%), 14 deep infections (3.5%), 2 neurological
injuries (0,5%) and 5 clinical deep venous thromboses (1.2%) (2 pulmonary embolisms). The survival
rate at 25 years, both for stem and cup, was 83%. Survival was higher in those arthroplasties
implanted in patients older than 60 years, with statistical significance.
Conclusion: Low Friction Arthroplasty undertaken at general hospitals by general orthopaedic
surgeons feature similar outcomes to those found in centres devoted to hip surgery.
Background
Low Friction Arthroplasty (LFA) is still considered the
"golden guide" when it comes to compare the different
Total Hip Arthroplasy (THA) models. Many studies have
been published on LFA, showing excellent, long-term
results, both about clinical and radiological issues [1,2] as
well as about survival analyses [3-5]. Nevertheless, most
of these studies include series of LFA undertaken at hospi-
tals which were pioneers in this technique [6], or which
were devoted to hip surgery procedures. Some studies
have raised the question about whether the good results
obtained with the Charnley prosthesis could be replicated
at general hospitals when it comes to the frequency of
early complications and failure rates, both of which
would be higher than those published [7]. Survival analy-
sis is a powerful tool for analysing the results of total joint
replacements despite the objections found in the litera-
ture [8], but it has major drawbacks when the failure rates
are very low.
Our Unit belongs to a general hospital located in northern
Spain, and it serves a population of 180,000; it is not spe-
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the hospital has remained faithful to LFA throughout the
years (Figure 1). Our aim is to know the long term behav-
iour of these arthroplasties by studying any eventual com-
plications which may have arisen and by conducting a
survival analysis.
Methods
404 LFA (294 patients) performed as primary procedures
consecutively from 1976 to 1993 have been included in
this study. In all cases the implant used was the prosthesis
designed by J. Charnley, with the technical and design
improvements added throughout the years [9]. The surgi-
cal procedures were undertaken by a team of six general
orthopaedic surgeons following a homogeneous tech-
nique, always using a Smith-Petersen anterior approach
without performing the osteotomy of the greater tro-
chanter. The senior surgeon (DHV) had previously
attended to the Center for Hip Surgery at Wrightington,
England in 1976 and 1979 to learn the original technique.
No mechanical cementing system was used.
Throughout 2004, two independent observers who did
not participate in the surgery (ASV and JFL) reviewed the
medical histories and radiographies of each patient, cate-
gorizing the radiographs into those that were possibly,
probably or definitely loose. General data about the
patient and the intervention as well as about the clinical
development were gathered. Since we are dealing with a
long-term, retrospective study, only easily verifiable varia-
bles (age, sex, side) were accepted. Any complications
which required an active medical intervention and which,
accordingly, were featured in the medical histories, were
also included.
For the survival analysis, the end-point chosen would be
the chirurgical revision of any of the prosthetic compo-
nents for whatever reason. Variable data (time, event, age
and sex) were recorded in a SIGMASTAT v 3.00 for Win-
dows (SPSS, Inc., Chicago, IL) database built for such pur-
pose. The survival calculations were done with this tool,
following the Kaplan-Meier method [10] with a confi-
dence interval of 95%. The equality of survival distribu-
tions was contrasted for the acetabulum and stem
components through the Log Rank test. In every hypothe-
sis test, only p < 0.05 values were considered statistically
significant.
Results
The mean age at the moment of surgery was of 67 years
(SD: 8.8), where the maximum age was 91 years and the
minimum was 36. 57% of the cases were males and 43%
females; 45% were right side and 55%, left side.
The following complications were registered: 16 disloca-
tions (4%), 14 deep infections (3.5%), 5 periprosthetic
fractures (1.2%), 2 neurological injuries (in the crural
nerve and 1 in the sciatic nerve), 5 deep venous thrombo-
ses (1.2%) with 2 pulmonary embolisms, one of them
fatal.
After 25 years, the cup and stem survival rates were of 83%
(Table 1 and 2), (Figure 2). A 55.2% of arthroplasties were
lost by dead of patients and 20% by unknown causes [see
Table 1: Survival rate of the cup
Follow-up (years) LFA Cup survival (%)
5 307 96
10 235 93
15 128 91
20 57 89
25 10 83
Low friction arthroplasty with 22 years follow-upFigure 1
Low friction arthroplasty with 22 years follow-up. No 
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strated a better behaviour at the beginning of the follow-
up, but at the end it equals that of the femoral stem
(though it has no statistical significance). Figure 3 shows
the survival curve of the components after grouping the
series according to the age of the patients (younger and
older than 60 years). Survival was higher in those arthro-
plasties implanted in patients older than 60 years, with
statistical significance in the Log Rank test, both for the
acetabular component (p = 0.008) and the femoral stem
component (p = 0.043), with a higher difference between
the curves as development time increases. There were no
differences related to sex.
Discussion
A surgical technique is reproducible if its results are simi-
lar in real, non-ideal, conditions, and that is what seems
to happen with LFA. In the long term, the survival rate of
LFA in our centre is very similar to those shown in histor-
ical series or arthroplasty register [11,12] and in those cen-
tres devoted to hip surgery [3,4,13] The worst survival rate
Survival curve of the components after grouping the series according to the age of the patientsFigure 3
Survival curve of the components after grouping the series according to the age of the patients.
 
Table 2: Survival rate of the stem
Follow-up (years) LFA Stem survival (%)
5 305 95
10 230 92
15 123 87
20 52 83
25 10 83
Kaplan-Meier survival curve showing the cumulative survival per yearFigure 2
Kaplan-Meier survival curve showing the cumulative 
survival per year.
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proved [12]. In the short-term, however, our survival rate
is worse than those found in the aforementioned series,
being closer to the results expressed by Fender et al [7].
Our deep infection rate is high, since it includes proce-
dures undertaken in a time when antibiotic prophylaxis
was not systematically used and this may justify, if only
partially, such results.
Both in our series as well as in a multicentric series [14],
the global survival rate was of 83% after 20 years. There
are, however, some minor differences when we analyze
the survival of each component on its own, around 87%
for each of them in Older's multicentric series, and 83%
and 89% for the acetabular and stems, respectively, in our
series.
The dislocation rate is also higher than the classical rate of
2%–3% for primary surgery [15] being closer to 3.9%,
which can be found in those studies undertaken at general
facilities [16]. However, it is still inferior to that published
by Fender et al which reached 5%.
The assessment of results in THA requires a multiple
approach, either through clinical score sets comple-
mented with imaging analyses, curves or survival analysis,
or through score and review indices about the quality of
life related to health. Each approach addresses a require-
ment of the complex evaluation of this technique which,
paradoxically enough, must be reviewed in the long term
in spite of being relatively new and rapidly evolving in
developed countries.
There remain many unresolved questions in hip replace-
ment. Well-constructed clinical tests offer the best hopes
of answering them. Such tests are onerous, and time and
money are required to collect, record and analyze the
data. The relatively few clinicians who undertake such
tests must have an understanding of the statistical meth-
ods used and the problems they may encounter. It is espe-
cially difficult to find series where you can compare long
term results in the literature and whether the arthroplasty
was implanted in general hospitals. Only retrospective
studies are available, which must be accepted in spite of
the known issues with validity. The methodological flaws
common to these studies could be alleviated using, as in
our case, data about which there is absolute certainty they
are true, even though this would mean an obvious loss of
information. In joint replacement surgery the usual end-
point is the decision to remove the prosthesis and revise
or convert it to some other form of treatment. This end-
point has been criticized because the criteria used to
decide the need for removal will differ between patients
and surgeons. This form of analysis defines a failure point
or terminal event and provides an assessment of not only
how many failures there had been but also how long after
the operation did the failure occur. It does not measure
function or pain, unless they are included in the defini-
tion of failure (Figure 4). Using a confidence interval of
95% in the survival curve allows a more faithful compari-
son of the best and worst possible results with those of
other series.
To sum up, our study seems to confirm a higher frequency
of early complications and a higher assessment rate of the
THA in general hospitals compared to those in dedicated
centres, although in the long term this trend does not keep
up and the survival rates become similar. LFA undertaken
Stem loosening in a Charnley arthroplasty (17 years follow-up)Figure 4
Stem loosening in a Charnley arthroplasty (17 years 
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at general hospitals by general orthopaedic surgeons fea-
ture similar outcomes to those found in centres devoted to
hip surgery. A national joint replacement registry would
be a useful tool to compare outcomes for high and low
volume community hospitals as well as academic centres.
Conclusion
Low Friction Arthroplasty undertaken at general hospitals
by general orthopaedic surgeons feature similar outcomes
to those found in centres devoted to hip surgery.
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